DFMLX | PEMGX | DFMLX / PEMGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 3 years | 19 years | - |
Gain YTD | 13.217 | 22.985 | 58% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000000 | 1000 | 10,000,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 418M | 29.3B | 1% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 27.29 | 28.88 | 94% |
Returns for 3 years | -9.42 | 2.40 | -392% |
Returns for 5 years | N/A | 47.78 | - |
Returns for 10 years | N/A | 102.98 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SBMLX | 24.86 | -0.26 | -1.04% |
ClearBridge Mid Cap C | |||
TLAFX | 13.73 | -0.18 | -1.29% |
Transamerica Large Core ESG R4 | |||
EADIX | 16.95 | -0.23 | -1.34% |
Eaton Vance Global Equity Income A | |||
CTOGX | 15.59 | -0.30 | -1.89% |
Calamos Timpani SMID Growth R6 | |||
SHSSX | 72.11 | -1.74 | -2.36% |
BlackRock Health Sciences Opps Instl |